RK

Rakesh Kumar Singhal

Active Director Director DIN 10089130
DIN 10089130 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Rakesh Kumar Singhal

Data last updated:

Rakesh Kumar Singhal is a Director at Rarra Healthcare Private Limited (since 2023). Rarra Healthcare Private Limited reported revenue of ₹23.3 Lakh (FY 2025).

DIN 10089130
Primary Designation Director
First Appointment 26 Mar 2023
Oldest Company Age 3 yrs
Largest company Rarra Healthcare Private Limited · ₹23.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rarra Healthcare Private Limited U86901UP2023PTC178968
Director26 Mar 20232023₹23.3 Lakh (FY 2025)Active

Board colleagues of Rakesh Kumar Singhal

Directorship timeline

Open interactive timeline →
Rarra Healthcare Private Limited
Premium access

Shareholding and investment profile for Rakesh Kumar Singhal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rakesh Kumar Singhal

Rakesh Kumar Singhal currently holds 1 directorship: Rarra Healthcare Private Limited (Director, since 26 Mar 2023, revenue ₹23.3 Lakh (FY 2025)).

Rakesh Kumar Singhal was first appointed on 26 Mar 2023 as Director at Rarra Healthcare Private Limited.

The current boards of Rakesh Kumar Singhal's companies include Harsh Singhal (Rarra Healthcare Private Limited), Suresh Kumar Gupta (Rarra Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available